MICHAEL SHER: Open Payments
NPI 1336149707 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,915 in 65 payments from 11 companies in 2025. Trend: 2023 $1,505 · 2024 $1,010 · 2025 $1,915
Food & beverage: $1,915
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $577 |
| PFIZER INC. | 17 | $372 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $282 |
| Novo Nordisk Inc | 7 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $150 |
| ABBVIE INC. | 1 | $125 |
| Esperion Therapeutics, Inc. | 6 | $92 |
| Lilly USA, LLC | 2 | $39 |
| Exact Sciences Corporation | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: FARXIGA, JARDIANCE, BREZTRI, NURTEC ODT, Ozempic, TRINTELLIX, PAXLOVID, QULIPTA.
Industry payments across NJ — which companies pay providers there.
